Skip to content

Clinical trials

Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Country / region: United States Clear all

462 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200014
200114
200211
200314
200414
200517
200618
200722
200822
200916
201023
201123
201212
201320
201419
201512
201618
201717
201814
201913
202013
202112
20229
20236
20249
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed266
Terminated60
Recruiting49
Active, not recruiting49
Withdrawn13
Unknown status11
Available5
No longer available5
Approved for marketing1
Suspended1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)68
Memorial Sloan Kettering Cancer Center50
Children's Oncology Group46
New Approaches to Neuroblastoma Therapy Consortium24
St. Jude Children's Research Hospital23
Giselle Sholler18
Baylor College of Medicine14
Fred Hutchinson Cancer Center14
Dana-Farber Cancer Institute9
Emory University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma462
Sarcoma105
Osteosarcoma103
Wilms Tumor97
Rhabdomyosarcoma82
Medulloblastoma73
Sarcoma, Ewing72
Lymphoma, Non-Hodgkin65
Neoplasms62
Recurrence61

Trials

Showing 1 to 25 of 462. Each trial links to its page on Pharma Observatory.

362 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.